‘A corrupt deal’: Probe sought into handing over of 5 airports including Mangaluru to Adani

Kalaburagi, Apr 20: With no COVID-19 case reported here on Sunday, the total number of virus-infected people in the district stood at 22.

While three persons have succumbed to the infection in the district so far, three others have been cured and discharged.

"No COVID-19 case was reported in Kalaburagi district today. Total 22 positive cases and 3 deaths have been reported in the district till date. Three persons have been cured," said District Magistrate B. Sharat.

Karnataka's total count of coronavirus patients has surged to 390, said the State Health Department on Sunday.

"Six new cases have been confirmed for COVID-19 in the State from 5 pm on Saturday till 5 pm on Sunday. Cumulatively, 390 COVID-19 positive cases have been confirmed in the state," it said.

Mysuru, Jul 19: Residents in the vicinity of the Chamundeshwari temple alleged VVIP racism against the administration for allowing BJP MP Shobha Karandlaje for a special visit there on Friday.

Even though the district collector had ordered the closure of temple visits due to the COVID pandemic, an exception was made for VVIPs.
The BJP leader claimed that she visited the temple on Thursday evening but the temple officials confirmed that she visited the temple on Friday at 7 am. It is her routine every year to visit the temple on the last Friday of Ashada Masa.

Locals, who tried get darshan of Chamundi Devi, were barred by the police leading to an altercation between locals and cops at the entrance to the temple.

Ashada Masa is considered an auspicious occasion and it is a belief among politicians that for the longevity of their political career, they need to visit Chamundeshwari temple every last Friday of Ashada Masa.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.